Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/21/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Diane Young

Wrong Dr. Diane Young?

Board of Trustees Member

Phone: (732) ***-****  HQ Phone
The Valerie Fund
2101 Millburn Ave.
Maplewood, New Jersey 07040
United States

Company Description: The Valerie Fund's mission is to provide support for the comprehensive health care of children with cancer and blood disorders.
Background

Employment History

Education

  • MD
  • M.D.
105 Total References
Web References
Board of Trustees
www.thevaleriefund.org, 21 Dec 2013 [cached]
Diane Young, M.D. - Novartis Click here to read biography Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.
PTCommunity.com - Daily News Briefing
www.pharmscope.com, 5 June 2005 [cached]
"The effectiveness of Gleevec in these five diseases further underscores how cancers and diseases of different origin and location can share common pathways that often respond to the same targeted treatment," said Diane Young, MD, Vice President and global head of Clinical Development at Novartis Oncology.
Board of Trustees - The Valerie Fund
www.thevaleriefund.org, 30 Oct 2009 [cached]
Diane Young, M.D., Novartis
...
Diane Young, M.D., Novartis Diane Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.
Media releases
www.novartis.com, 13 June 2008 [cached]
"Our robust clinical program with Glivec continues to provide meaningful insights into the treatment of Ph+ CML and other types of cancer," said Diane Young, MD, Head of Global Medical Affairs at Novartis Oncology.
EORTC Study: Progression-free survival improves for 800 mg vs. 400 mg patients
www.liferaftgroup.com, 4 April 2009 [cached]
"This latest study provides further evidence that Gleevec is a highly effective therapy for patients with advanced Kitpositive GIST, and offers insight into potential ways to improve long-term outcomes for these patients," said Diane Young, Vice President and global head of Clinical Development at Novartis Oncology.
Other People with the name "Young":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304